blood clots Press Release

Title Picture
10/17/2018 - 21:56
Fatal Blood Clots in Women: A Survivors Story
UTMB's picture
UTMB
10/16/2018 - 08:34
Nicotine is hard to quit
HelsinkiUniv's picture
HelsinkiUniv
10/14/2018 - 17:56
Genentechs Kadcyla Reduced the Risk of Disease Recurring in People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment
Genentech's picture
Genentech
10/11/2018 - 04:08
BioMarin and Believe Limited Announce Selection of 25 High School Students to Perform in First-of-its-Kind 'Hemophilia: The Musical'
BioMarin's picture
BioMarin
10/09/2018 - 10:26
World Thrombosis Day Campaign Commemorates Fifth Anniversary and Reaches Billions in Effort to Raise
ISTH's picture
ISTH
10/03/2018 - 19:01
FDA Approves Genentechs Hemlibra (Emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors
Genentech's picture
Genentech
10/02/2018 - 07:55
Shire Joins World Thrombosis Day Campaign as Global Supporter
ISTH's picture
ISTH
09/28/2018 - 04:57
FDA Approves Genentech's Xolair (Omalizumab) Prefilled Syringe Formulation
Genentech's picture
Genentech
09/26/2018 - 20:59
BD Joins World Thrombosis Day Campaign as Global Contributor to Raise Awareness of Blood Clots
ISTH's picture
ISTH
09/13/2018 - 01:55
FDA Approves On-Ambulance Phase 2 Clinical Trial for Treatment of Acute Stroke
VABIO's picture
VABIO
09/04/2018 - 23:58
Genentech to Present New Data from Its Extensive Lung Cancer Program at the 2018 World Conference on Lung Cancer (WCLC)
Genentech's picture
Genentech
09/03/2018 - 23:12
Severe Complications Rise Sharply Among Women Giving Birth in Hospitals
AHRQ's picture
AHRQ
08/29/2018 - 12:30
Diagnostic device can help prevent strokes and heart attacks
ANUniversity's picture
ANUniversity
08/29/2018 - 11:38
Positive Phase III Results for Genentechs HEMLIBRA (emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors Published in New England Journal of Medicine
Genentech's picture
Genentech
08/29/2018 - 03:47
European Commission approves Novartis combination therapy Tafinlar + Mekinist for adjuvant treatment of BRAF V600 mutation-positive melanoma
Novartis's picture
Novartis
08/27/2018 - 05:07
Researcher finds new blood clot prevention strategy
Feinstein Institute's picture
Feinstein Institute
08/20/2018 - 13:11
FDA Accepts Priority Review of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the US
Alexion's picture
Alexion
08/12/2018 - 10:07
FDA Grants Breakthrough Therapy Designation for Xolair (Omalizumab) for Food Allergies
Genentech's picture
Genentech
08/06/2018 - 03:31
A stent-free future for common cardiovascular ailments
University of Wisconsin's picture
University of W...
07/31/2018 - 09:24
Providers seek to find ways to unlock ROI on records systems
HIMSS's picture
HIMSS
07/27/2018 - 17:06
Novartis combination Tafinlar + Mekinist receives positive CHMP opinion for adjuvant treatment of BRAF V600 mutation-positive melanoma
Novartis's picture
Novartis
07/25/2018 - 11:45
Genentech Unveils Positive Phase II Results for the First-Ever Eye Implant to Achieve Sustained Delivery of a Biologic Medicine to Treat People With Wet Age-Related Macular Degeneration (AMD)
Genentech's picture
Genentech
07/24/2018 - 16:37
Depression and antidepressants are associated with an increased risk of venous thromboembolism
University of Bristol's picture
University of B...
07/23/2018 - 16:59
FIRST ISCHEMIC STROKE PATIENTS TREATED WITH EMBOTRAP II REVASCULARIZATION DEVICE SINCE COMMERCIAL AVAILABILITY IN U.S.
Johnson and Johnson's picture
Johnson and Johnson
07/20/2018 - 01:13
Vein Health: PAD, DVT and Uterine Artery Embolization
Cone Health's picture
Cone Health
07/17/2018 - 18:05
FDA Grants Breakthrough Therapy Designation for Genentechs TECENTRIQ in Combination With Avastin as First-Line Treatment for Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Genentech's picture
Genentech
07/11/2018 - 00:28
Leo Pharma A/S Joins World Thrombosis Day Campaign as Global Patron to Raise Awareness
ISTH's picture
ISTH
06/27/2018 - 23:26
Alexion Submits Application for Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the European Union (EU)
Alexion's picture
Alexion
06/26/2018 - 21:45
Westpac backs two female nanotechnologists with prestigious research fellowship
Westpac's picture
Westpac
06/20/2018 - 00:09
Blue Cross and Blue Shield Designated Hospitals Report Lower C-section Rates and Improved Health of Mothers and Children
Blue Cross Blue Shield Association's picture
Blue Cross Blue...
06/19/2018 - 18:00
Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
Alexion's picture
Alexion
06/15/2018 - 12:31
Feinstein Institute scientist recognized for anticoagulation management practices
Feinstein Institute's picture
Feinstein Institute
06/15/2018 - 09:29
Novartis study of real-world data concludes Jakavi is associated with a reduction in risk of death and dangerous blood clots for patients with rare blood cancer
Novartis's picture
Novartis
06/14/2018 - 13:31
Alexion Announces Selection of Positive Phase 3 Clinical Data for ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) for Late-Breaking Oral Presentation at Annual Conference of the European Hematology Association (EHA)
Alexion's picture
Alexion
06/14/2018 - 07:33
New discovery about the brains water system may prove beneficial in stroke
UniversityofCopenhagen's picture
UniversityofCop...
06/14/2018 - 03:01
MERCURY PE is the first prospective, randomized trial to evaluate emergency department discharge in U.S. patients with low-risk PE
Johnson and Johnson's picture
Johnson and Johnson
06/13/2018 - 12:03
FDA Approves Genentechs Avastin (Bevacizumab) Plus Chemotherapy as a Treatment for Women With Advanced Ovarian Cancer Following Initial Surgery
Genentech's picture
Genentech
06/11/2018 - 14:25
New phone app will help treat blood clots
UTMB's picture
UTMB
06/04/2018 - 12:11
Pioneering Thrombosis Researcher Selected to Lead Newborn Medicine Program at Childrens Hospital of Pittsburgh of UPMC
Children's Hospital of Pittsburgh's picture
Children's Hosp...
06/04/2018 - 05:29
FDA Grants Priority Review to Genentechs HEMLIBRA (emicizumab-kxwh) for People With Hemophilia A Without Factor VIII Inhibitors
Genentech's picture
Genentech
05/29/2018 - 19:34
FDA expedites review of Novartis drug Promacta for first-line severe aplastic anemia (SAA)
Novartis's picture
Novartis
05/23/2018 - 09:29
Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
Abbott's picture
Abbott
05/21/2018 - 11:04
FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure
FDA's picture
FDA
05/17/2018 - 16:01
BioMarin Announces 1 Platform and 3 Poster Presentations at World Federation of Hemophilia 2018 World Congress
BioMarin's picture
BioMarin
05/16/2018 - 12:09
Animal Medical Center Leads Global 10-Year Study to Improve Feline Health: Feline Cardiovascular Risk Study Spans 21 Countries
Animal Medical Center of New York's picture
Animal Medical ...
05/16/2018 - 11:07
Stroke Prevention Drug Combo Shows Promise, Study Says
University of Texas's picture
University of Texas
05/15/2018 - 13:21
FDA approves first epoetin alfa biosimilar for the treatment of anemia
FDA's picture
FDA
05/15/2018 - 10:04
Pfizers Biosimilar RETACRIT (epoetin alfa-epbx) Approved by U.S. FDA
Pfizer's picture
Pfizer
05/15/2018 - 07:38
BioMarin Announces First Patient Dosed in Phase 1/2 Study Evaluating Valoctocogene Roxaparvovec Gene Therapy in Severe Hemophilia A Patients with Pre-existing AAV5 Antibodies
BioMarin's picture
BioMarin
05/15/2018 - 04:25
Groundswell of support for Atrial Fibrillation research leads to $15.75 million in philanthropic giving
American Heart Association's picture
American Heart ...
05/12/2018 - 20:52
Genentech to Present New Phase III Data for HEMLIBRA (emicizumab-kxwh) in People With Hemophilia A at the World Federation of Hemophilia 2018 World Congress
Genentech's picture
Genentech
05/10/2018 - 09:31
Patients who have had an irregular heart beat can't ever be considered 'cured', say researchers
University of Birmingham's picture
University of B...
05/05/2018 - 23:51
FDA Grants Priority Review to Genentechs Cancer Immunotherapy Tecentriq (Atezolizumab) for Initial Treatment of People With a Specific Type of Metastatic Lung Cancer
Genentech's picture
Genentech
05/04/2018 - 09:07
FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer
FDA's picture
FDA
05/03/2018 - 06:57
Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter
Abbott's picture
Abbott
05/02/2018 - 09:36
Abbott's XIENCE Sierra Heart Stent Receives National Reimbursement in Japan to Treat People with Coronary Artery Disease
Abbott's picture
Abbott
05/01/2018 - 08:26
Single injection treats hemophilia B for life, in proof-of-concept study
Salk Institute's picture
Salk Institute
04/30/2018 - 07:04
Actelion Submits Supplemental New Drug Application to US FDA Seeking Approval of OPSUMIT (macitentan) for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Johnson and Johnson's picture
Johnson and Johnson
04/25/2018 - 05:35
ISTH Partners with McMaster University to Publish a Guideline on Thrombotic Thrombocytopenic Purpura
ISTH's picture
ISTH
04/16/2018 - 00:54
FDA Grants Breakthrough Therapy Designation For Genentechs HEMLIBRA (emicizumab-kxwh) in Hemophilia A Without Inhibitors
Genentech's picture
Genentech